Pharmaceutical Industry In Japan Contributes ¥1.1 Billion To Politicians
This article was originally published in PharmAsia News
Executive SummaryThe pharmaceutical industry contributed ¥1.1 billion to both the ruling Liberal Democratic Party and the Democratic Party of Japan, according to a report released by Sankei News. The number puts the drug industry as a leading contributor among other industries. In 2006, a Japan pharmaceutical PAC was ranked among the top 10 contributors and was the only industry group except an Osaka small enterprise association. (Click here for more - Japanese language)
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.